Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
09/2007
09/04/2007US7265205 For use in the capture and/or purification of biotinylated proteins
09/04/2007US7265204 Nematode PAN and ZP receptor-like sequences
09/04/2007US7265202 PIAS molecules that recognize and bind STAT proteins and uses thereof
09/04/2007US7265085 Glycoconjugation methods and proteins/peptides produced by the methods
09/04/2007US7265084 Removing saccharyl subunit from peptide to form truncated glycan; contacting with glycosyltransferase and at least one glycosyl donor comprising polyoxyethylene glycol
09/04/2007US7265083 Administering to an animal a biologically effective amount of a pharmaceutically acceptable CXC chemokine formulation that comprises an XXX-CXC chemokine other than PF4, the XXX-CXC chemokine lacking the amino acid sequence ELR (Glu Leu Arg)
09/04/2007US7264965 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
09/04/2007US7264963 Modular replicable vector; module flanked by DNA cleavage site in a nucleotide sequence; antibody gene as a universal framework for highly diverse antibody libraries
09/04/2007US7264805 Proteins with a high immunoreactivity and a method for the production thereof
09/04/2007US7264703 Gel trap for electrophoresis
08/2007
08/30/2007WO2007097903A2 Hiv fusion inhibitor peptides with improved biological properties
08/30/2007WO2007097406A1 Hydrophilic carbon cluster
08/30/2007WO2007097361A1 Immunoglobulin affinity ligand
08/30/2007WO2007097254A1 Novel isodipeptide
08/30/2007WO2007077365A3 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs
08/30/2007WO2007022012A3 Differentially protected orthogonal lanthionine technology
08/30/2007WO2007018759A3 Ligand-binding reagents for quenching and improved purification of lipidated proteins
08/30/2007US20070199821 Automated two-dimensional gel electrophoresis
08/30/2007CA2651793A1 Hiv fusion inhibitor peptides with improved biological properties
08/30/2007CA2638777A1 Novel isodipeptide
08/29/2007EP1826569A1 Identifying material from a breast duct
08/29/2007EP1826270A1 Method and library for in vitro selection
08/29/2007EP1826217A1 Method for identification of antigenic peptides
08/29/2007EP1824875A1 Plant proteins having an abscisic acid binding site and methods of use
08/29/2007EP1824796A2 Protein scaffolds and uses thereof
08/29/2007EP1824510A2 Use of flagellin in the immunotherapy of yersinia pestis
08/29/2007EP1425006B1 Reference control for high-sensitivity c-reactive protein testing
08/29/2007EP1259120B1 Method for isolating collagen from marine sponge and producing nanoparticulate collagen, and the use thereof
08/29/2007EP1009814B1 Human receptor tyrosine kinase, kdr
08/29/2007EP0950067B1 Affinity purification of polypeptide on protein a matrix
08/29/2007EP0942930B1 Purification of neurotrophins
08/29/2007CN101027322A 促红细胞生成素受体结合抗体 Erythropoietin receptor antibody
08/29/2007CN101027315A Method for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins
08/29/2007CN101027080A Methods of protein fractionation using high performance tangential flow filtration
08/29/2007CN101027047A Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
08/29/2007CN101024824A A method for the inactivation and removal of dengue virus from biological samples
08/29/2007CN101024670A Soluble maize protein, its preparing method and use
08/29/2007CN101024669A Soluble polysaccharide protein cross-link antigen preparing method
08/29/2007CN100334208C A method for extracting superoxide dismutase
08/29/2007CN100334113C Method for enhancing antiseptic peptide stability and its application
08/29/2007CN100334105C Method for separation and purification of streptavidin by means of nano magnetic particles
08/28/2007US7262283 Facilitates the isolation of proteins from the cell nucleus interior as an independent fraction by separating the complete proteome into partial proteomes and thus makes this fraction available for further analyses for the first time in adequate purity and quality
08/28/2007US7262281 using cell surface layer proteins as carrier of functional molecules, wherein solution containing S-layer proteins in form of monomers or oligomers is brought into contact with carrier surface and two-dimensional crystalline structure is configured
08/28/2007US7262280 G-protein fusion receptors and constructs encoding same
08/28/2007US7262275 Graft polymer of polyester and polypeptide; prevent cyclization
08/28/2007US7262273 Diagnosing and prognosing pancreatic and blood clotting disorders via detection of allelic changes in g-protein coupled receptor amino acid sequences
08/28/2007US7262270 Ectodomain of the HIV-1IIIB envelope glycoprotein gp41 fused to a fragment of the influenza virus HA2 hemagglutinin protein. Immunization in vivo via an intraperitoneal prime followed by intranasal or intragastric boosts with gp41HA
08/28/2007US7262169 Process for preparing peptide intermediates
08/28/2007US7262058 Method for determining lipid associated sialoprotein in body fluids
08/28/2007US7262036 Preparation of L-lysine by culturing a Coryneform bacteria having an overexpressed zwa1 polynucleotide that encodes a polypeptide having a specific amino acid sequence in a medium suitable for expression of the zwa1 polynucleotide
08/28/2007US7262034 Using bacillus culture to generate vitamin b5; bioreactors
08/28/2007US7262016 Providing a plurality of microdevices, providing a microchannel array, introducing of microdevices into microchannels; rotating microdevices within microchannels by a magnetic force, whereby a combined effect of magnetic force and preferential axis of magnetization of microdevices separates microdevices
08/28/2007US7261901 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections
08/28/2007US7261897 Fusion proteins of mycobacterium tuberculosis
08/28/2007CA2203373C Process for improved recombinant production of disulphide bond-containing polypeptides via a protein disulfide isomerase
08/28/2007CA2125763C P40 homodimer of interleukin-12
08/23/2007WO2007094760A1 Vectors and methods for identifying proteins amenable to crystallization
08/23/2007WO2007094739A1 Method of processing a biological and/or chemical sample
08/23/2007WO2007094668A1 Affinity regions
08/23/2007WO2007094269A1 Method for efficient purification of bionanocapsule
08/23/2007WO2007094248A1 Process for producing proteoglycan
08/23/2007WO2007093548A1 Method for the manufacture of lantibiotics
08/23/2007WO2007093014A1 Methods for the synthesis of two or more dicarba bridges in organic compounds
08/23/2007WO2007093013A1 Methods for the synthesis of dicarba bridges in organic compounds
08/23/2007WO2007093012A1 Conotoxin analogues, and methods for synthesis of intramolecular dicarba bridge containing peptides
08/23/2007WO2007001677A9 Compositions and methods for immunomodulation in an organism
08/23/2007WO2006113139A3 Method of altering the binding specificity of proteins by oxidation-reduction reactions
08/23/2007WO2004018698A3 Lectin compositions and methods for modulating an immune response to an antigen
08/23/2007US20070197772 Methods for preparing internally constrained peptides and peptidomimetics
08/23/2007US20070197477 Phosphonium salts derivatives
08/23/2007US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
08/23/2007CA2642828A1 Affinity regions
08/23/2007CA2641763A1 Method for the manufacture of lantibiotics
08/22/2007EP1820858A1 Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
08/22/2007EP1820806A1 Affinity regions
08/22/2007EP1819820A1 Protein isolation and purification
08/22/2007EP1819731A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
08/22/2007EP1819730A2 Method of producing antibodies
08/22/2007EP1664087B1 Prion clearance using particulate metal oxides
08/22/2007EP1501542B1 Improved polysaccharide and glycoconjugate vaccines
08/22/2007EP1402024B1 Templated molecules and methods for using such molecules
08/22/2007EP1397216B1 Method for parallel synthesis and transfer of molecules to a substrate
08/22/2007EP1303292A4 Chemokine conjugates
08/22/2007EP0773950B1 Linked peptide nucleic acids
08/22/2007CN1333247C Buffered split flow device in use for electrophoresis of free stream
08/22/2007CN1332981C Degreasing and deliming process for extracting collagen from fish scale
08/22/2007CN1332977C Novel techykinin peptides, precursor peptides thereof and genes encoding the same
08/22/2007CN1332976C Method of anticipating interaction between proteins
08/22/2007CN1332718C Silica gel carrier protein A immune absorption material and its preparation method
08/22/2007CN101020714A Earthworm protein with function of lowering blood pressure and its prepn process
08/22/2007CN101020709A Process of extracting collagen from chromium-containing waste leather
08/21/2007US7259254 Isolated, hybrid nucleic acids capable of binding to ligand; transcription activation
08/21/2007US7259249 Method for preparing conjugates of proteins and chelating agents
08/21/2007US7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same
08/21/2007US7259243 Process for isolation of osteopontin from milk
08/21/2007US7259242 Protein molecular weight ladder made of a fusion protein that comprises thioredoxin, a modified thioredoxin, or a truncated thioredoxin.
08/21/2007US7259241 With an amino acid sequence encoded by the the nucleotide sequence AveC homolog gene product from S. hygroscopicus
08/21/2007US7259239 Nucleotide sequences coding glycosyltransferase for use in identification of modulators which prevent and treat bacterial infection; bactericides
08/21/2007US7259237 Reducing the disulfide bond in a precursor molecule of viral neuraminidase inhibitors, subsequently alkylating the reduced disulfide bonds with an alkylating agent.
08/21/2007US7259232 Preferred segments of neural thread protein